Most Chemotherapy Administration Sites Are Rural: Evidence From the Minnesota All-Payer Claims Database and a Framework for State-Level Cancer Care Surveillance

PURPOSE: Chemotherapy is widely assumed to be concentrated in urban cancer centers, but state-level data on its geographic distribution are limited. We used the Minnesota All-Payer Claims Database (MN APCD) to characterize rural and urban chemotherapy administration sites, assess quality certification rates, and present a replicable methodology for other states. METHODS: Claims for carboplatin (J9045) and paclitaxel (J9264, J9267) from the 2022 MN APCD were analyzed. Chemotherapy administration sites were identified from billing claims, geolocated, and assigned Rural-Urban Commuting Area (RUCA) codes (urban: 1-3; rural: 4-10). Quality Oncology Practice Initiative (QOPI) certification and Commission on Cancer (CoC) accreditation were matched by facility. National QOPI (N = 217) and CoC (N = 1,093) data were analyzed by RUCA category for comparison. RESULTS: 42.9%). Nationally, rural practices comprised 14.7% of QOPI-certified sites and 13.4% of CoC-accredited programs, 15%-20% of the US population living in rural areas. CONCLUSION: Despite published ASCO workforce data showing that only 7%-11.7% of medical oncologists practice in rural areas, 52.9% of Minnesota chemotherapy administration sites are rural, challenging the assumption that chemotherapy delivery is an urban and suburban phenomenon. Rural sites deliver 27.0% of claim volume, suggesting a broadly distributed but lower-intensity rural oncology infrastructure invisible to workforce-based mapping. This APCD-based framework is scalable and replicable; with approximately 25 states operating or developing mandatory APCDs, it can inform cancer control planning, direct resources to where care is delivered, and help close rural oncology disparities nationwide.

Authors

Institutions

Publication Details

Journal
JCO Oncology Practice
Published
2026-11-17
DOI
https://doi.org/10.1200/op-26-00505
Primary Topic
Healthcare Policy and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Most Chemotherapy Administration Sites Are Rural: Evidence From the Minnesota All-Payer Claims Database and a Framework for State-Level Cancer Care Surveillance

Joshua C. Pritchett, Wade Thomas Swenson, Aquino Williams, Abigail Paige Swenson et al.
3 links
JCO Oncology Practice
Healthcare Policy and Management
article

Most Chemotherapy Administration Sites Are Rural: Evidence From the Minnesota All-Payer Claims Database and a Framework for State-Level Cancer Care Surveillance

Joshua C. Pritchett, Wade Thomas Swenson, Aquino Williams, Abigail Paige Swenson, Zachary Schroeder, Ingrid E. Jacobson, Gillian A. Northrup, Anika Eldien, Collin Kray, Andrew Foster Armstrong, Mark Mitchell, Aidan Swenson
article en

Abstract

PURPOSE: Chemotherapy is widely assumed to be concentrated in urban cancer centers, but state-level data on its geographic distribution are limited. We used the Minnesota All-Payer Claims Database (MN APCD) to characterize rural and urban chemotherapy administration sites, assess quality certification rates, and present a replicable methodology for other states. METHODS: Claims for carboplatin (J9045) and paclitaxel (J9264, J9267) from the 2022 MN APCD were analyzed. Chemotherapy administration sites were identified from billing claims, geolocated, and assigned Rural-Urban Commuting Area (RUCA) codes (urban: 1-3; rural: 4-10). Quality Oncology Practice Initiative (QOPI) certification and Commission on Cancer (CoC) accreditation were matched by facility. National QOPI (N = 217) and CoC (N = 1,093) data were analyzed by RUCA category for comparison. RESULTS: 42.9%). Nationally, rural practices comprised 14.7% of QOPI-certified sites and 13.4% of CoC-accredited programs, 15%-20% of the US population living in rural areas. CONCLUSION: Despite published ASCO workforce data showing that only 7%-11.7% of medical oncologists practice in rural areas, 52.9% of Minnesota chemotherapy administration sites are rural, challenging the assumption that chemotherapy delivery is an urban and suburban phenomenon. Rural sites deliver 27.0% of claim volume, suggesting a broadly distributed but lower-intensity rural oncology infrastructure invisible to workforce-based mapping. This APCD-based framework is scalable and replicable; with approximately 25 states operating or developing mandatory APCDs, it can inform cancer control planning, direct resources to where care is delivered, and help close rural oncology disparities nationwide.

JCO Oncology Practice
Texas Christian University (US), University of Minnesota (US), Mayo Clinic (US), University of Tennessee Health Science Center (US), Medical College of Wisconsin (US), University of Minnesota, Duluth (US), Wake Forest University Health Sciences (US), Rural Cancer Institute (US), Wake Forest University (US), College of Saint Benedict and Saint John's University (US)
Good health and well-being, Reduced inequalities
Healthcare Policy and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon